NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free HCAT Stock Alerts $7.53 +0.09 (+1.21%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$7.47▼$7.7450-Day Range$7.44▼$10.7652-Week Range$6.60▼$14.37Volume539,921 shsAverage Volume626,690 shsMarket Capitalization$440.96 millionP/E RatioN/ADividend YieldN/APrice Target$12.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Health Catalyst alerts: Email Address Health Catalyst MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.69 Rating ScoreUpside/Downside66.0% Upside$12.50 Price TargetShort InterestHealthy3.11% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment1.16Based on 2 Articles This WeekInsider TradingSelling Shares$34,255 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.47) to ($0.28) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.79 out of 5 starsMedical Sector57th out of 939 stocksComputer Programming, Data Processing, & Other Computer Related Industry3rd out of 56 stocks 4.3 Analyst's Opinion Consensus RatingHealth Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.69, and is based on 9 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.50, Health Catalyst has a forecasted upside of 66.0% from its current price of $7.53.Amount of Analyst CoverageHealth Catalyst has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.11% of the outstanding shares of Health Catalyst have been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Health Catalyst has recently increased by 6.43%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHealth Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.Environmental SustainabilityThe Environmental Impact score for Health Catalyst is -0.91. Previous Next 3.4 News and Social Media Coverage News SentimentHealth Catalyst has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Health Catalyst this week, compared to 3 articles on an average week.Search Interest10 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 900% compared to the previous 30 days.MarketBeat Follows7 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,255.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.47) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -3.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -3.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW About Health Catalyst Stock (NASDAQ:HCAT)Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.Read More HCAT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HCAT Stock News HeadlinesMarch 22, 2024 | americanbankingnews.comCritical Survey: Health Catalyst (NASDAQ:HCAT) & System1 (NYSE:SST)March 20, 2024 | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.March 17, 2024 | finance.yahoo.comHCAT Dec 2024 10.000 putMarch 17, 2024 | finance.yahoo.comHCAT Apr 2024 7.500 putMarch 16, 2024 | finance.yahoo.comHCAT Apr 2024 10.000 callMarch 16, 2024 | finance.yahoo.comHCAT Dec 2024 17.500 callMarch 11, 2024 | msn.comScientists design bifunctional catalyst to address environmental pollution problemsMarch 29, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.March 9, 2024 | seekingalpha.comHealth Catalyst: Achieving FY28 Long-Term Guidance Is PossibleMarch 5, 2024 | finance.yahoo.comDaniel Burton Bought 3.2% More Shares In Health CatalystMarch 4, 2024 | finance.yahoo.comHealth Catalyst to Participate in Upcoming Investor ConferencesFebruary 28, 2024 | msn.comHealth Catalyst rises following disclosure of CEO share purchaseFebruary 27, 2024 | prnewswire.comHealth Catalyst Names UnityPoint Health Winner of the 2024 Flywheel AwardFebruary 27, 2024 | finance.yahoo.comThe 2024 Healthcare Analytics Summit (HAS) Kicks Off TodayFebruary 26, 2024 | markets.businessinsider.comMaintaining Buy Rating on Health Catalyst: Strong Sales Pipeline and Margin Outlook Offset Slower Growth ForecastFebruary 24, 2024 | ca.finance.yahoo.comBank of Canada to cut interest rates in half by end of next year: DesjardinsFebruary 24, 2024 | finance.yahoo.comHealth Catalyst Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 23, 2024 | markets.businessinsider.comOptimistic Outlook: Health Catalyst’s Growth and Profitability Potential Affirm Buy RatingFebruary 23, 2024 | markets.businessinsider.comAnalyst Scoreboard: 5 Ratings For Health CatalystFebruary 23, 2024 | finance.yahoo.comHealth Catalyst, Inc. (NASDAQ:HCAT) Q4 2023 Earnings Call TranscriptFebruary 23, 2024 | finance.yahoo.comQ4 2023 Health Catalyst Inc Earnings CallFebruary 22, 2024 | msn.comHealth Catalyst GAAP EPS of -$0.53 misses by $0.18, revenue of $75.08M beats by $1.49MFebruary 22, 2024 | finance.yahoo.comHealth Catalyst (NASDAQ:HCAT) Exceeds Q4 Expectations But Full-Year Guidance UnderwhelmsFebruary 22, 2024 | finance.yahoo.comHealth Catalyst Inc (HCAT) Reports Revenue Growth and Margin Expansion in Q4 and Full Year 2023 ...February 22, 2024 | globenewswire.comHealth Catalyst Reports Fourth Quarter and Year End 2023 ResultsFebruary 21, 2024 | finance.yahoo.comHealth Catalyst's MeasureAble™ Earns ONC Health IT CertificationSee More Headlines Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today3/29/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Computer programming, data processing, & other computer related Sub-IndustryN/A Current SymbolNASDAQ:HCAT CUSIPN/A CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$12.50 High Stock Price Target$16.00 Low Stock Price Target$8.00 Potential Upside/Downside+66.0%Consensus RatingModerate Buy Rating Score (0-4)2.69 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)($2.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-118,150,000.00 Net Margins-39.92% Pretax Margin-39.80% Return on Equity-12.19% Return on Assets-6.51% Debt Debt-to-Equity Ratio0.62 Current Ratio4.42 Quick Ratio4.42 Sales & Book Value Annual Sales$295.94 million Price / Sales1.49 Cash FlowN/A Price / Cash FlowN/A Book Value$6.38 per share Price / Book1.18Miscellaneous Outstanding Shares58,560,000Free Float56,982,000Market Cap$440.96 million OptionableOptionable Beta1.30 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Daniel D. Burton (Age 48)CEO & Director Comp: $158.9kMr. Daniel H. Orenstein (Age 54)Senior Advisor Comp: $356.56kMr. Bryan Truman Hunt (Age 37)Senior Advisor Comp: $370.46kMr. Kevin Freeman (Age 51)Chief Commercial Officer Comp: $405.9kMr. Jason Alger (Age 40)CFO & Chief Accounting Officer Mr. Daniel LeSueurChief Operating OfficerMr. Dave RossChief Technology OfficerMr. Adam BrownSenior Vice President of Investor Relations and Financial Planning & AnalysisMr. Benjamin LandryGeneral Counsel & Secretary of the BoardMs. Tarah Neujahr BryanChief Marketing & Communications OfficerMore ExecutivesKey CompetitorsbioteNASDAQ:BTMDiTeos TherapeuticsNASDAQ:ITOSZimVieNASDAQ:ZIMVLifeMDNASDAQ:LFMDArbutus BiopharmaNASDAQ:ABUSView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 933,735 shares on 3/11/2024Ownership: 9.406%Goldman Sachs Group Inc.Bought 335,823 shares on 3/1/2024Ownership: 2.084%Price T Rowe Associates Inc. MDBought 4,941 shares on 2/16/2024Ownership: 0.082%GSA Capital Partners LLPBought 39,854 shares on 2/16/2024Ownership: 0.069%Vident Advisory LLCBought 2,939 shares on 2/15/2024Ownership: 0.034%View All Insider TransactionsView All Institutional Transactions HCAT Stock Analysis - Frequently Asked Questions Should I buy or sell Health Catalyst stock right now? 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HCAT shares. View HCAT analyst ratings or view top-rated stocks. What is Health Catalyst's stock price target for 2024? 13 brokers have issued twelve-month price objectives for Health Catalyst's stock. Their HCAT share price targets range from $8.00 to $16.00. On average, they predict the company's stock price to reach $12.50 in the next twelve months. This suggests a possible upside of 66.0% from the stock's current price. View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts. How have HCAT shares performed in 2024? Health Catalyst's stock was trading at $9.26 at the beginning of 2024. Since then, HCAT stock has decreased by 18.7% and is now trading at $7.53. View the best growth stocks for 2024 here. When is Health Catalyst's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our HCAT earnings forecast. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) released its earnings results on Thursday, February, 22nd. The company reported ($0.21) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The firm had revenue of $75.08 million for the quarter, compared to analysts' expectations of $73.67 million. Health Catalyst had a negative trailing twelve-month return on equity of 12.19% and a negative net margin of 39.92%. What ETFs hold Health Catalyst's stock? ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR FactSet Innovative Technology ETF (XITK) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Health Catalyst issued on next quarter's earnings? Health Catalyst issued an update on its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $72.5 million-$76.5 million, compared to the consensus revenue estimate of $79.0 million. What is Dan Burton's approval rating as Health Catalyst's CEO? 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL). When did Health Catalyst IPO? Health Catalyst (HCAT) raised $129 million in an initial public offering on Thursday, July 25th 2019. The company issued 6,000,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Health Catalyst's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.57%), Vanguard Group Inc. (9.41%), Point72 Asset Management L.P. (7.22%), Impax Asset Management Group plc (3.05%), Dimensional Fund Advisors LP (2.69%) and Primecap Management Co. CA (2.47%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn and Paul Horstmeier. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HCAT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.